SARAH KALINA: Open Payments
NPI 1194038968 · TALENT, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$273 in 12 payments from 6 companies in 2025. Trend: 2023 $97 · 2024 $246 · 2025 $273
Food & beverage: $273
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $84 |
| Novo Nordisk Inc | 3 | $59 |
| Lundbeck LLC | 2 | $56 |
| Astellas Pharma US Inc | 2 | $43 |
| Lilly USA, LLC | 1 | $17 |
| Exact Sciences Corporation | 1 | $15 |
Products named: REXULTI, Veozah, Wegovy, CREON, QULIPTA, UBRELVY, Ozempic, MOUNJARO.
Industry payments across OR — which companies pay providers there.
